Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels. (scientific article published on 10 November 2016)

Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins.

Q53541654

Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids

Q74294396

Degradation of the G protein-coupled receptor kinase 2 by the proteasome pathway

Q77696868

Adapted changes in left ventricular structure and function in severe uncomplicated obesity

Q80984809

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

Q26775037

Structural Basis for the Regulation of Protein Kinase A by Activation Loop Phosphorylation

Q27677271

Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice

Q28272272

Beta-arrestin- and c-Src-dependent degradation of G-protein-coupled receptor kinase 2

Q28359741

Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133

Q29617856

Insulin Signaling and Heart Failure.

Q30377910

G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure

Q30487539

Lipotoxicity in the heart

Q33665107

Mitochondrial and cellular mechanisms for managing lipid excess

Q33978623

Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations.

Q34297183

Lipoapoptosis: its mechanism and its diseases

Q35047180

G-protein-coupled receptor kinase 2-mediated desensitization of adiponectin receptor 1 in failing heart

Q35528402

G protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity

Q35757227

Modern science versus the stigma of obesity

Q35788028

Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence

Q35846888

The evolving impact of g protein-coupled receptor kinases in cardiac health and disease

Q36000382

Reversal of diet-induced obesity and insulin resistance by inducible genetic ablation of GRK2.

Q36100307

Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease

Q36313343

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Ph

Q36354637

Insulin treatment increases myocardial ceramide accumulation and disrupts cardiometabolic function

Q36383552

GRK2 compromises cardiomyocyte mitochondrial function by diminishing fatty acid-mediated oxygen consumption and increasing superoxide levels

Q36399800

The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux

Q36430696

Adiposity of the heart, revisited

Q36439598

Adipose tissue biology and cardiomyopathy: translational implications

Q36496035

Inhibition of G-protein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice

Q36548326

Lipotoxic heart disease in obese rats: implications for human obesity

Q37117677

GRK mythology: G-protein receptor kinases in cardiovascular disease

Q37396870

AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure

Q37834161

Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity.

Q37845219

G Protein-coupled receptor kinase 2 (GRK2): A novel modulator of insulin resistance

Q37880070

G protein-coupled receptor kinases in normal and failing myocardium

Q37881660

PGC-1 coactivators in the cardiovascular system.

Q37952044

Current mapping of obesity

Q38134787

The pathophysiology of heart failure with preserved ejection fraction.

Q38222648

Downregulation of G protein-coupled receptor kinase 2 levels enhances cardiac insulin sensitivity and switches on cardioprotective gene expression patterns

Q38304071

Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity

Q38317857

Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.

Q38321475

Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice

Q38352186

Cardiac lipid accumulation associated with diastolic dysfunction in obese mice.

Q38352512

Mitochondrial dynamics, mitophagy and cardiovascular disease.

Q38625440

AMP-activated protein kinase phosphorylates transcription factors of the CREB family

Q40038541

Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-alpha-induced insulin resistance

Q40177903

Short Term Palmitate Supply Impairs Intestinal Insulin Signaling via Ceramide Production

Q42395469

GRK2 contribution to the regulation of energy expenditure and brown fat function

Q42505116

Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase

Q44771333

Control of myocardial contractile function by the level of beta-adrenergic receptor kinase 1 in gene-targeted mice

Q47859877

P275

Creative Commons Attribution 4.0 International

copyrighted

describes a project that uses

ImageJ

Q1659584

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

obesity

Q12174

G protein-coupled receptor

Q38173

P304

page(s)

155

P577

publication date

2016-11-10

P1433

published in

Cardiovascular Diabetology

Q2468083

P1476

title

Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels

P478

volume

Reverse relations

cites work (P2860)

Q91823408	A high-content, in vitro cardiac fibrosis assay for high-throughput, phenotypic identification of compounds with anti-fibrotic activity
Q55261192	Biochemical and Ultrastructural Cardiac Changes Induced by High-Fat Diet in Female and Male Prepubertal Rabbits.
Q64229774	G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases
Q45874891	GRK2 as a therapeutic target for heart failure
Q47649685	Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity.
Q39159635	Insulin and β Adrenergic Receptor Signaling: Crosstalk in Heart
Q46034115	Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.
Q89506074	Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors
Q90411593	Restricting mitochondrial GRK2 post-ischemia confers cardioprotection by reducing myocyte death and maintaining glucose oxidation
Q64090294	Soluble Receptor for Advanced Glycation End Products: A Protective Molecule against Intramyocardial Lipid Accumulation in Obese Zucker Rats?
Q39107039	Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies
Q61444355	The Impact of Cardiac Lipotoxicity on Cardiac Function and Mirnas Signature in Obese and Non-Obese Rats with Myocardial Infarction